The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis
出版年份 2023 全文链接
标题
The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-09-09
DOI
10.1016/j.cmi.2023.09.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
- (2023) Anne J Gonzales-Luna et al. LANCET INFECTIOUS DISEASES
- Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study
- (2022) Ronza Najjar-Debbiny et al. INFECTION
- Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials
- (2022) Sho Tashiro et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis
- (2022) Jianfeng Dai et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
- (2022) Marcela Krutova et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection
- (2022) J. Xin Liao et al. PHARMACOTHERAPY
- Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study
- (2021) Jacek Czepiel et al. Antibiotics-Basel
- Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
- (2021) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
- (2021) Joffrey van Prehn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
- (2020) Erik R Dubberke et al. Open Forum Infectious Diseases
- Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective, observational, database study in England
- (2020) David A. Enoch et al. JOURNAL OF HOSPITAL INFECTION
- Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection
- (2019) Christian Lodberg Hvas et al. GASTROENTEROLOGY
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis
- (2019) Hiroyuki Okumura et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of fidaxomicin for the treatment of Clostridioides ( Clostridium ) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
- (2018) Hiroshige Mikamo et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
- (2018) Benoit Guery et al. LANCET INFECTIOUS DISEASES
- Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
- (2018) Jung Hoon Song et al. Gut and Liver
- Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
- (2016) Kamal Desai et al. BMC INFECTIOUS DISEASES
- Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States
- (2016) Andrew F. Shorr et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin
- (2016) Abrar K. Thabit et al. Annals of Clinical Microbiology and Antimicrobials
- Recurrent Clostridium difficile infection is associated with increased mortality
- (2015) M.A. Olsen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin
- (2015) Seth T. Housman et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin
- (2013) J. A. Leeds et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- Potential for Transmission of Clostridium difficile by Asymptomatic Acute Care Patients and Long-Term Care Facility Residents with Prior C. difficile Infection
- (2012) Sadao Jinno et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Review of the Management of FulminantClostridium difficileInfection
- (2008) M. Raffat Jaber et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search